Dr. Ritu Goel shares her insights that "run-in periods" and strict study thresholds can underestimate side effects by pre-filtering sensitive patients before trials begin. This creates data reflecting those who already tolerate statins rather than the average person starting therapy. Such high statistical bars may mask subjective symptoms like muscle pain, read the full article to learn more.